NCT06833060 - Transscleral Selective Laser Trabeculoplasty Project | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions

Glaucoma,Open-AngleOcular Hypertension (OH)

Interventions

DEVICE

Selective Laser Trabeculoplasty

Treatment of Glaucoma or Ocular Hypertension participants using Transscleral Selective Laser Trabeculoplasty

Trial Locations (1)

RECRUITING

Central Adelaide Local Health Network - Royal Adelaide Hospital, Adelaide

All Listed Sponsors

collaborator

Quantel Medical

INDUSTRY

lead

Lumibird Medical (Quantel Medical, Ellex Medical, Optotek)

INDUSTRY